UK scientist wins NC3Rs prize
For improving the welfare of laboratory mice
Prizewinner Jane Hurst's research has shown that a new way of handling laboratory mice can improve their welfare and the quality of the science they are used for.
Laboratory mice are usually picked up by their tails, which according to Hurst's study causes high levels of anxiety and stress to the animals that can influence the outcome of experiments. By simply catching the mice using a plastic tunnel or cupped hands anxiety can be greatly reduced.
The number of mice used in the UK annually is approximately 2.6 million.
Hurst, from the University of Liverpool, received a £10,000 prize grant, which is sponsored by GlaxoSmithKline (GSK), plus a personal award of £1,000. She plans to use the prize to provide training for scientists and animal care staff on handling methods and also to assess the effects of different handling methods on stress physiology.
‘I hope our research will be universally implemented across laboratories to improve animal welfare for all mice and to minimise the effects of handling on experiments. This is a small change that is easily applied and will make a big difference to animal welfare,’ she said.
The NC3Rs prize recognises and rewards excellence in research that helps to reduce the number and suffering of animals used for scientific purposes.
The Wellcome Trust and NC3Rs also funded the research.
The research was published in Nature Methods magazine.
You may also like
Regulatory
MoonLake Immunotherapeutics faces Securities Class Action after disastrous Phase III trial results
The announcement about the trial results for the product candidate sonelokimab, a highly anticipated treatment for patients with skin disease, saw MoonLake investors' shares fall by about 90%, prompting an investigation into whether or not they were misled
Manufacturing
Roquette opens pharmaceutical innovation centre in Brazil
The Health & Pharma Solutions facility in São Paolo offers state-of-the-art laboratories for customers, with the Northeast Center for Strategic Technologies partnering with Roquette to empower young women to pursue careers in science through the Futuras Cientistas programme at the facility
Manufacturing
Samsung Bioepis and Phrontline join forces to advance best-in-class antibody-drug conjugate therapeutics for solid tumours
The pair will co-develop two investigational ADC assets directed against targets expressed in a broad range of cancers, adding a new class of bispecific and dual-payload ADC therapeutics to Samsung Bioepis' oncology portfolio
Research & Development
AlzeCure Pharma publishes response letter clarifying Alzstatin’s distinct mechanism in Alzheimer’s treatment
AlzeCure Pharma and leading academic collaborators have published a response in JPET addressing recent commentary on Alzstatin’s γ-secretase modulation data, reaffirming the promise of lead candidate ACD680 in Alzheimer’s therapy